AGGRIBLOC 5MG/100ML Infusion

Price 6711 INR/ Thousand

Get a Price/Quote

AGGRIBLOC 5MG/100ML Infusion Specification

Dosage Form
Infusion

Salt Composition
Tirofiban Hydrochloride

Pacakaging (Quantity Per Box)
1 infusion bottle per box

Origin of Medicine
Synthetic

Indication
Unstable angina, non-ST elevation myocardial infarction (NSTEMI), patients undergoing percutaneous coronary intervention (PCI)

Drug Type
Allopathic

Ingredients
Tirofiban Hydrochloride

Physical Form
Liquid

Function
Glycoprotein IIb/IIIa receptor antagonist, platelet aggregation inhibitor

Recommended For
Adults requiring reduction of thrombotic cardiovascular events

Dosage
5 mg/100 ml intravenous infusion

Dosage Guidelines
Administer as directed by physician

Suitable For
Adults

Quantity
100 ml

Storage Instructions
Store below 25C, protect from light, do not freeze

Clinical Use
Adjunct to percutaneous coronary intervention

Route of Administration
Intravenous

Therapeutic Class
Antiplatelet agent

Shelf Life
24 months

Container Type
Glass vial

Appearance
Clear, colorless solution

Contraindications
Active internal bleeding, recent major surgery, severe uncontrolled hypertension

Marketed By
Abbott

Expiry
Check packaging for expiry date

Prescription Required
Yes

Side Effects
Bleeding, thrombocytopenia, hypotension

About AGGRIBLOC 5MG/100ML Infusion

AGGRIBLOC 5MG/100ML Infusion is a blood thinner which prevents formation of harmful blood clots. It helps to prevent a heart attack in patients presenting with severe chest pain due to a sudden decrease in blood flow to the heart.AGGRIBLOC 5MG/100ML Infusion is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long term treatment even after this injection.Common side effects of this medicine include headaches, hematoma, nausea, ecchymosis, postoperative bleeding, and blood in stool or urine. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool.This medicine is used with caution for some people. Before taking it, you must inform the doctor if you are suffering from any bleeding disorder, kidney, or liver disease. Also, let your doctor know if you are breastfeeding and about all the other medications that you are taking regularly

How Does AGGRIBLOC Infusion Work?

AGGRIBLOC contains Tirofiban Hydrochloride, a synthetic antiplatelet agent. It acts by selectively blocking glycoprotein IIb/IIIa receptors on platelets, reducing their ability to clump together and form harmful clots. This mechanism helps in lowering the risk of thrombotic cardiovascular events, especially during or after certain cardiac procedures.

Clinical Applications and Recommended Usage

AGGRIBLOC 5MG/100ML is commonly used as an adjunct during percutaneous coronary interventions (PCI) for adults with unstable angina or non-ST elevation myocardial infarction (NSTEMI). It is administered intravenously by healthcare professionals, strictly following physician-established dosage and monitoring guidelines to ensure optimal efficacy and safety.

Proper Handling and Storage Instructions

To maintain its effectiveness, AGGRIBLOC should be stored below 25C, kept away from direct light, and should never be frozen. It is provided in a glass vial and must be handled using aseptic techniques in a clinical setting. Always check the packaging for the expiry date before use.

FAQ's of AGGRIBLOC 5MG/100ML Infusion:

Q: What is AGGRIBLOC 5MG/100ML Infusion used for?

A: AGGRIBLOC is used as an adjunct to percutaneous coronary intervention in adults dealing with unstable angina or non-ST elevation myocardial infarction (NSTEMI). Its main function is to prevent blood clots by inhibiting platelet aggregation.

Q: How should AGGRIBLOC Infusion be administered?

A: This medication is meant for intravenous use only and must be administered by a healthcare professional. The dosage and duration are determined by the treating physician based on the individual patient's condition.

Q: When is AGGRIBLOC contraindicated?

A: AGGRIBLOC should not be used in patients experiencing active internal bleeding, those who have had recent major surgery, or individuals with severe uncontrolled hypertension. Always inform your doctor of any medical history before starting the treatment.

Q: What side effects may occur with AGGRIBLOC Infusion?

A: Possible side effects of AGGRIBLOC include bleeding, reduced platelet count (thrombocytopenia), and low blood pressure (hypotension). If you experience any unusual symptoms or reactions, notify your healthcare provider promptly.

Q: Where should AGGRIBLOC be stored?

A: AGGRIBLOC should be stored in a cool environment below 25C, protected from light, and must not be frozen. Always refer to the vial packaging for specific expiry dates and other storage guidelines.

Q: What are the benefits of using AGGRIBLOC in PCI procedures?

A: The main benefit is its ability to reduce the risk of clot formation during and after percutaneous coronary intervention, thereby minimizing potential complications in high-risk heart patients.

Tell us about your requirement